CH0523961370 - Common Stock
NLS PHARMACEUTICS LTD
NASDAQ:NLSP (7/26/2024, 7:00:01 PM)
After market: 0.1877 0 (-1.21%)0.19
-0.01 (-3.16%)
NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 3 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
NLS PHARMACEUTICS LTD
The Circle 6
Zurich ZUERICH CH-6370
P: 41445122150
CEO: Alexander Zwyer
Employees: 3
Website: https://nlspharma.com/
Palantir stock is on the rise Thursday as PLTR investors react to a new $19 million contract for the big data and AI company.
NLS Pharmaceutics stock is down on Thursday as shares of NLSP come off of a recent rally that was fueled by heavy trading on Tuesday.
Pre-market stock movers are a hot topic on Thursday and we have all the hottest news behind these movements this morning!
Quantum stock is down on Tuesday as investors in QMCO shares react to the company's earnings report for fiscal 2024 this morning.
Aerwins Technologies stock is falling hard on Tuesday as investors in AWIN shares prepare for them to be delisted this morning.
Actelis Networks stock is up with heavy trading of ASNS shares after signing Carahsoft Technology as a new supply partner.
Here you can normally see the latest stock twits on NLSP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: